Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.
Thomas P A DanneBertrand CariouJohn B BuseSatish K GargJulio RosenstockPhillip BanksJake A KushnerDarren K McGuireAnne L PetersSangeeta SawhneyPaul StrumphPublished in: Diabetes care (2019)
Combined with optimized insulin in type 1 diabetes, sotagliflozin significantly increased glucose TIR without increasing time spent at <3.9 mmol/L and reduced PPG, thereby improving glycemic control.